DrugPatentWatch Database Preview
Loperamide hydrochloride - Generic Drug Details
» See Plans and Pricing
What are the generic drug sources for loperamide hydrochloride and what is the scope of patent protection?
Loperamide hydrochloride
is the generic ingredient in six branded drugs marketed by J And J Consumer Inc, Bionpharma Inc, Mylan, Roxane, Teva, Yaopharma Co Ltd, Janssen Pharms, Akorn, Allied, Alpharma Us Pharms, Duramed Pharms Barr, Perrigo, Watson Labs, Wockhardt Bio Ag, Perrigo R And D, Able, Aurobindo Pharma Ltd, Contract Pharmacal, L Perrigo Co, LNK, Ohm Labs, and Sun Pharm Inds Ltd, and is included in thirty-three NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.There are eleven drug master file entries for loperamide hydrochloride. Ninety-nine suppliers are listed for this compound.
Summary for loperamide hydrochloride
| US Patents: | 1 |
| Tradenames: | 6 |
| Applicants: | 22 |
| NDAs: | 33 |
| Drug Master File Entries: | 11 |
| Suppliers / Packagers: | 99 |
| Bulk Api Vendors: | 96 |
| Clinical Trials: | 67 |
| Patent Applications: | 5,574 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | loperamide hydrochloride at DailyMed |
Recent Clinical Trials for loperamide hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Takeda | Phase 2 |
| SOLTI Breast Cancer Research Group | Phase 2 |
| Jiangsu HengRui Medicine Co., Ltd. | Phase 1 |
Pharmacology for loperamide hydrochloride
| Drug Class | Opioid Agonist |
| Mechanism of Action | Opioid Agonists |
Medical Subject Heading (MeSH) Categories for loperamide hydrochloride
US Patents and Regulatory Information for loperamide hydrochloride
Expired US Patents for loperamide hydrochloride
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| J And J Consumer Inc | IMODIUM | loperamide hydrochloride | CAPSULE;ORAL | 017694-001 | Approved Prior to Jan 1, 1982 | Start Trial | Start Trial |
| Janssen Pharms | IMODIUM | loperamide hydrochloride | SOLUTION;ORAL | 019037-001 | Jul 31, 1984 | Start Trial | Start Trial |
| J And J Consumer Inc | IMODIUM A-D | loperamide hydrochloride | SOLUTION;ORAL | 019487-001 | Mar 1, 1988 | Start Trial | Start Trial |
| J And J Consumer Inc | IMODIUM A-D EZ CHEWS | loperamide hydrochloride | TABLET, CHEWABLE;ORAL | 020448-001 | Jul 24, 1997 | Start Trial | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2021 - 2022
NCE-1 Patent Challenge Dates 2021 - 2022
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2021, www.DrugPatentWatch.com.
Follow DrugPatentWatch:
